Editor in Chief :

Mahmoud Ashraf Ibrahim ,MD

      Issues per Volume: Quarterly
Current Volume: 1
Current Issue : 1

Volume 1 number 1 Summer 2003
Special issue for the abstracts of the 7th Pan Arab Conference on Diabetes
PACD7 , 25 – 28 March 2003 Cairo

 

Abstract Number : 18
MICROALBUMINURIA IN DIABETICS TREATED WITH ANGIOTENSIN
CONVERSION ENZYME

Maher BEJI, Tunisia

Department of internal Medicine, military hospital Gabes, Gabès 6000 Tunisia..

Diabetes mellitus is the most common cause of end-stage renal disease. Prevention consists on screening test to detect diabetic nephropathy early. The measure of MICROALBUMINURIA allowed developing the concept of premature nephropathy.

The aim of this study was to evaluate the effect of ANGIOTENSIN conversion enzyme (ACE) inhibitors on MICROALBUMINURIA and blood pressure in hypertensive and normotensive type 2 diabetic patients. We followed Fifty-five hypertensive and forty-four normotensive type 2 diabetic with MICROALBUMINURIA, age, BMI, risk factors, HbA (1c), diabetes duration, treatment with ACE inhibitors and MICROALBUMINURIA were studied in two groups. Our results confirm the protector effect of the ACE inhibitors in the diabetes type 2, they delay the progression from incipient to overt diabetic nephropathy and reduce albumin excretion rate, independently of blood pressure.


Go Back to Table of Contents

OnlineDiabetes Journal, All rights reserved